Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Treatment Failure »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Trastuzumab < Treatment Failure < Treatment Outcome  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000371 (2019) Tomoyuki Mutoh [Japon] ; Tomonori Ishii [Japon] ; Tsuyoshi Shirai [Japon] ; Kanae Akita [Japon] ; Yukiko Kamogawa [Japon] ; Yoko Fujita [Japon] ; Hiroko Sato [Japon] ; Yuko Shirota [Japon] ; Hiroshi Fujii [Japon] ; Hideo Harigae [Japon]Refractory Takayasu arteritis successfully treated with rituximab: case-based review.
000591 (2019) April Zhang [États-Unis] ; James Nocton [États-Unis] ; Yvonne Chiu [États-Unis]A Case of Pansclerotic Morphea Treated With Tocilizumab.
000649 (2018) Hilal Eser Ozturk [Turquie] ; Merih Oray [Turquie] ; Ilknur Tugal-Tutkun [Turquie]Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
000774 (2018) Lisa Baganz [Allemagne] ; Adrian Richter [Allemagne] ; Jörn Kekow [Allemagne] ; Arnold Bussmann [Allemagne] ; Andreas Krause [Allemagne] ; Carsten Stille [Allemagne] ; Joachim Listing [Allemagne] ; Angela Zink [Allemagne] ; Anja Strangfeld [Allemagne]Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
000829 (2018) Xiao-Chuan Sun [République populaire de Chine] ; Shuang Liu [République populaire de Chine] ; Chen Li [République populaire de Chine] ; Shuo Zhang [République populaire de Chine] ; Mu Wang [République populaire de Chine] ; Xiao-Hua Shi [République populaire de Chine] ; Wei-Xin Hao [République populaire de Chine] ; Wen Zhang [République populaire de Chine]Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report.
000885 (2018) Ettore Silvagni [Italie] ; Alessandra Bortoluzzi [Italie] ; Greta Carrara [Italie] ; Anna Zanetti [Italie] ; Marcello Govoni [Italie] ; Carlo Alberto Scirè [Italie]Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
000958 (2017) Cornelia Glaser [Allemagne] ; Siegbert Rieg [Allemagne] ; Thorsten Wiech [Allemagne] ; Christine Scholz [Allemagne] ; Dominique Endres [Allemagne] ; Oliver Stich [Allemagne] ; Peter Hasselblatt [Allemagne] ; Walter Gei Dörfer [Allemagne] ; Christian Bogdan [Allemagne] ; Annerose Serr [Allemagne] ; Georg H Cker [Allemagne] ; Reinhard E. Voll [Allemagne] ; Jens Thiel [Allemagne] ; Nils Venhoff [Allemagne]Whipple's disease mimicking rheumatoid arthritis can cause misdiagnosis and treatment failure.
000A27 (2017) Ennio Giulio Favalli [Italie] ; Maria Gabriella Raimondo [Italie] ; Andrea Becciolini [Italie] ; Chiara Crotti [Italie] ; Martina Biggioggero [Italie] ; Roberto Caporali [Italie]The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives.
000C11 (2017) Jasvinder A. Singh ; Alomgir Hossain ; Elizabeth Tanjong Ghogomu ; Amy S. Mudano [États-Unis] ; Lara J. Maxwell ; Rachelle Buchbinder ; Maria Angeles Lopez-Olivo ; Maria E. Suarez-Almazor ; Peter Tugwell ; George A. WellsBiologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
000C87 (2016) Maria-Cecilia Vieira [États-Unis] ; Samuel H. Zwillich [États-Unis] ; Jeroen P. Jansen [États-Unis] ; Brielan Smiechowski [États-Unis] ; Dean Spurden [Royaume-Uni] ; Gene V. Wallenstein [États-Unis]Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.
000D99 (2016) Toshihiko Komai [Japon] ; Hirofumi Shoda [Japon] ; Kenichi Yamaguchi [Japon] ; Keiichi Sakurai [Japon] ; Mihoko Shibuya [Japon] ; Kanae Kubo [Japon] ; Toshiyuki Takahashi [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
000E98 (2016) Tristan Pascart [France] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non-TNF inhibitor failure: results from a multicentre study.
000E99 (2016) Young Ho Lee [Corée du Sud] ; Sang-Cheol Bae [Corée du Sud]Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
000F21 (2016) Jasvinder A. Singh ; Alomgir Hossain ; Elizabeth Tanjong Ghogomu ; Amy S. Mudano ; Peter Tugwell ; George A. WellsBiologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
001011 (2015) Helen L. Wright [Royaume-Uni] ; Devesh Mewar [Royaume-Uni] ; Roger C. Bucknall [Royaume-Uni] ; Steven W. Edwards [Royaume-Uni] ; Robert J. Moots [Royaume-Uni]Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab.
001118 (2015) William Terreaux ; Stéphanie Mestrallet ; Marion Fauconier ; Jean-Loup Pennaforte [France] ; Christian Penalba ; Jean-Paul Eschard ; Jean-Hugues Salmon [France]Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm.
001208 (2015) Surabhi Waghmare ; Bernardas Valecka ; Andrew P. CairnsA SEVERE CASE OF ADULT ONSET STILLS DISEASE WITH MYOPERICARDITIS, RESISTANT TO TREATMENT WITH TOCILIZUMAB BUT RESPONSIVE TO ANAKINRA.
001276 (2014) Ennio Giulio Favalli [Italie] ; Martina Biggioggero [Italie] ; Antonio Marchesoni [Italie] ; Pier Luigi Meroni [Italie]Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.
001341 (2014) Hiba M. Shendi [Royaume-Uni] ; Lisa A. Devlin ; John David EdgarInterleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome.
001363 (2014) Francisco Ortiz-Sanjuán [Espagne] ; Ricardo Blanco ; Vanesa Calvo-Rio ; Javier Narvaez ; Esteban Rubio Romero ; Alejandro Olivé ; Santos Casta Eda ; Adela Gallego Flores ; M Victoria Hernández ; Cristina Mata ; Inmaculada Ros Vilamajo ; Walter Alberto Sifuentes Giraldo ; Miguel A. Caracuel ; Mercedes Freire ; Catalina G Mez Arango ; José Llobet ; Sara Manrique Arija ; Carlos Marras ; Concepci N Moll-Tuduri ; Chamaida Plasencia-Rodriguez ; Rosa Rosell ; Ana Urruticoechea ; Maria L. Velloso-Feijoo ; Jordi Del Blanco ; M Carmen González-Vela ; Javier Rueda-Gotor ; Trinitario Pina ; Javier Loricera ; Miguel A. González-GayEfficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
001368 (2014) Mark C. Genovese [États-Unis] ; Roy Fleischmann [États-Unis] ; Daniel Furst [États-Unis] ; Namieta Janssen [États-Unis] ; John Carter [États-Unis] ; Bhaskar Dasgupta [Royaume-Uni] ; Judy Bryson [États-Unis] ; Benjamin Duncan [États-Unis] ; Wei Zhu [États-Unis] ; Costantino Pitzalis [Royaume-Uni] ; Patrick Durez [Belgique] ; Kosmas Kretsos [Royaume-Uni]Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Treatment Failure" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Treatment Failure" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Treatment Failure
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021